Display Settings:

Format

Send to:

Choose Destination
    J Med Chem. 2000 Jun 15;43(12):2324-31.

    Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.

    Source

    Preclinical Research, F. Hoffmann-La Roche Ltd., CH-4070 Basle, Switzerland.

    Abstract

    Low-molecular-weight beta-sulfonyl- and beta-sulfinylhydroxamic acid derivatives have been synthesized and found to be potent inhibitors of Escherichia coli peptide deformylase (PDF). Most of the compounds synthesized and tested displayed antibacterial activities that cover several pathogens found in respiratory tract infections, including Chlamydia pneumoniae, Mycoplasma pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. The potential of these compounds as antibacterial agents is discussed with respect to selectivity, intracellular concentrations in bacteria, and potential for resistance development.

    PMID:
    10882358
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk